Literature DB >> 8037886

Testosterone has rewarding affective properties in male rats: implications for the biological basis of sexual motivation.

G M Alexander1, M G Packard, M Hines.   

Abstract

Evidence from mammalian species, including humans, suggests that testosterone (T) enhances motivational aspects of sexual behavior, although the mechanism by which T exerts this effect is unknown. The hypothesis that increases in plasma T have rewarding affective properties was examined. Acute elevations of plasma T were induced in intact male rats by systemic administration of a recently developed testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex that mimics pulsatile release of the hormone. In a conditioned-place-preference paradigm, rats displayed a preference for an environment previously paired with T administration (800 micrograms/kg and 1,200 micrograms/kg) as opposed to an environment paired with saline administration, indicating that T has rewarding affective properties. The findings suggest that T may enhance motivational aspects of mammalian sexual behavior by facilitating acquisition or expression of learned associations between environmental stimuli and sexual activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037886     DOI: 10.1037//0735-7044.108.2.424

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  35 in total

1.  Posttraining androgens' enhancement of cognitive performance is temporally distinct from androgens' increases in affective behavior.

Authors:  C A Frye; E H Lacey
Journal:  Cogn Affect Behav Neurosci       Date:  2001-06       Impact factor: 3.282

2.  The testosterone metabolite 3α-diol enhances female rat sexual motivation when infused in the nucleus accumbens shell.

Authors:  Eliana L Sánchez Montoya; Lizaida Hernández; Jennifer L Barreto-Estrada; José G Ortiz; Juan Carlos Jorge
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

3.  Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment.

Authors:  Carrie McAllister; Jiangang Long; Adrienne Bowers; Aaron Walker; Philip Cao; Shin-Ichiro Honda; Nobuhiro Harada; Matthias Staufenbiel; Yong Shen; Rena Li
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 4.  Impact of socio-emotional context, brain development, and pubertal maturation on adolescent risk-taking.

Authors:  Ashley R Smith; Jason Chein; Laurence Steinberg
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

5.  Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol.

Authors:  Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2006-11-15       Impact factor: 3.533

6.  Sex and drugs: comment on "Evidence for involvement of erbeta and rgs9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior" by Silverman and Koenig.

Authors:  Ruth I Wood
Journal:  Horm Behav       Date:  2007-05-10       Impact factor: 3.587

Review 7.  Adolescents and androgens, receptors and rewards.

Authors:  Satoru M Sato; Kalynn M Schulz; Cheryl L Sisk; Ruth I Wood
Journal:  Horm Behav       Date:  2008-02-13       Impact factor: 3.587

8.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

Review 9.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

10.  Testosterone reinforcement: intravenous and intracerebroventricular self-administration in male rats and hamsters.

Authors:  Ruth I Wood; Luke R Johnson; Lucy Chu; Christina Schad; David W Self
Journal:  Psychopharmacology (Berl)       Date:  2003-10-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.